← Back
Data updated: Mar 10, 2026
YABAO PHARM
MetabolicOncology
YABAO PHARM is a generic drug manufacturer focused on Metabolic, Oncology.
2006
Since
4
Drugs
-
Trials
61
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CELECOXIB 2026-02-12
Labeling
CELECOXIB 2025-10-21
Labeling
CELECOXIB 2025-10-15
Labeling
CELECOXIB 2025-10-15
Labeling
CELECOXIB 2025-09-26
Labeling
CELECOXIB 2025-09-26
Labeling
CELECOXIB 2025-09-26
Labeling
CELECOXIB 2025-08-04
Labeling
CELECOXIB 2025-07-14
CELECOXIB 2025-04-29
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 71%
1 drugs Phase 2: 1 Phase 1: 7
Oncology 29%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2006-07-19
- Latest
- 2024-11-21
- Applications
- 4